Charles Russell Speechlys advises the ex-CEO of Cable & Wireless
Charles Russell Speechlys has acted as the legal adviser to Tony Rice, the ex-CEO of Cable & Wireless on his investment in Shields Environmental, the rapidly expanding telecoms managed services provider.
The investment was to back the company’s expanding services business. Senior management also invested in the company as part of the transaction.
For over 35 years Shields have been the world leaders in optimising network assets for telecoms operators across the globe. Shields help turn cost centres into revenue streams and, as a result, Shields have enabled their clients to manage their networks with the maximum financial efficiency and care for the environment.
Tony Rice stated: “I’m delighted to become Chairman of Shields and to be investing in a business that has a product range and capability that can provide operators with a unique, end to end capability ranging from spares management and inventory dimensioning right through to asset management and software. We are well placed to work with telecom operators to improve their network and cost efficiency in markets, most of which are fully penetrated and mature. "
Commenting on the transaction, Malcolm MacDougall, Partner and head of Private Equity at Charles Russell Speechlys, said: "We are delighted to have advised Tony on his investment in Shields Environmental. Shields Environmental is a rapidly expanding company and we look forward to assisting Tony and the management team as they grow the business. ”
The Charles Russell Speechlys team was led by Partner Malcolm MacDougall, and Private Equity Associates Richard Coleman and Emily Davies, as well as members of the Corporate Tax, Employment and Banking & Finance teams.
Tony was also advised from a corporate finance perspective by Matthew Katz of Buzzacott.
News & Insights
Charles Russell Speechlys double shortlisted for 2017 British Legal Awards
We are delighted to be shortlisted for Private Equity and Private Client team of the year.
Charles Russell Speechlys advises Kreos Capital on its €15 million growth capital investment
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer.
Charles Russell Speechlys advises Kreos Capital and Silicon Valley Bank on growth capital investment to Mereo BioPharma
Mereo BioPharma is a UK-based specialty bio-pharmaceutical company listed on the AIM market of the London Stock Exchange.
Charles Russell Speechlys shortlisted for 'Service Provider of the Year' in the Investor Allstars Awards
We are delighted to be recognised for our Venture and Growth Capital work.